Table 4 The clinical metrics of ground-truth and predicted dose distribution using MSE loss and sharp loss (γ = 100)
Ground truth | Predicted dose | ||
|---|---|---|---|
MSE loss | Sharp loss (γ = 100) | ||
PTV | |||
D95 (cGy) | 5000.0 ± 0.0 | 4795.09 ± 173.60 | 4963 ± 96.30 |
HI | 0.12 ± 0.03 | 0.42 ± 0.04 | 0.19 ± 0.02 |
CI | 0.83 ± 0.04 | 0.56 ± 0.08 | 0.77 ± 0.63 |
Heart | |||
Mean (cGy) | 625.42 ± 125.20 | 538.19 ± 147.21 | 644.46 ± 143.68 |
V30 (%) | 4.73 ± 1.94 | 3.0 ± 1.77 | 4.03 ± 1.77 |
Ipsilateral lung | |||
Mean (cGy) | 1065.04 ± 46.28 | 978.22 ± 73.49 | 1094.99 ± 125.57 |
V5 (%) | 42.63 ± 2.73 | 44.8 ± 2.53 | 45.57 ± 4.13 |
V20 (%) | 19.21 ± 1.18 | 17.02 ± 1.99 | 18.82 ± 3.12 |
V30 (%) | 13.34 ± 1.28 | 9.76 ± 1.78 | 12.99 ± 2.60 |
Whole lung | |||
Mean (cGy) | 597.11 ± 67.89 | 545.82 ± 52.60 | 623.70 ± 87.46 |
V5 (%) | 24.31 ± 5.90 | 23.22 ± 2.31 | 22.94 ± 3.45 |
V20 (%) | 9.02 ± 1.04 | 7.99 ± 1.12 | 8.87 ± 1.83 |
V30 (%) | 6.28 ± 0.86 | 4.61 ± 0.81 | 6.15 ± 1.48 |